Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05825001 · ClinicalTrials.gov registry record · NA
Evaluating the Episodic Future Thinking Intervention for Reducing Cigarette Consumption in Cigarette Smokers
A NA study of Cigarette Smoking-Related Carcinoma, sponsored by Roswell Park Cancer Institute.
- Active
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 1
- Study location
NCT05825001: Active NA study of Cigarette Smoking-Related Carcinoma, sponsored by Roswell Park Cancer Institute.
NCT05825001 is a NA study of Cigarette Smoking-Related Carcinoma that is active but no longer recruiting, run by Roswell Park Cancer Institute. The registered enrollment target is 104 participants, below the 462-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05825001, a NA study of Cigarette Smoking-Related Carcinoma, is active but no longer recruiting, sponsored by Roswell Park Cancer Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial evaluates the effectiveness of active episodic future thinking (EFT) stimuli for reducing cigarette consumption in cigarette smokers. EFT is an innovative framing method shown to significantly activate brain regions involved in future thinking, planning, and other executive functions. Active EFT stimuli are positive events, unrelated to smoking, that participants anticipate, look forward to, and can vividly imagine happening up to 1 year in the future. Control EFT stimuli are positive past events, unrelated to smoking, that participants can vividly remember happening in the recent past. Active EFT stimuli may help reduce cigarette consumption among cigarette smokers by exposing them to personally relevant future oriented stimuli.
Primary Outcome
Will be measured by Micro+Basic carbon monoxide monitor
Conditions Studied
Interventions
- BEHAVIORAL Smoking Cessation Intervention
- OTHER Medical Device Usage and Evaluation
- BEHAVIORAL Smoking Cessation Intervention (control)
Study Locations (1)
New York
- Roswell Park Comprehensive Cancer Center - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2024-09-15 |
| Est. Completion | 2026-10-01 |
| Phase | NA |
What the registry record for NCT05825001 still lists
NCT05825001 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 462-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Cigarette Smoking-Related Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Smoking Cessation Intervention is the first listed.
NCT05825001 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05825001 about?
NCT05825001 is a clinical study titled "Evaluating the Episodic Future Thinking Intervention for Reducing Cigarette Consumption in Cigarette Smokers". This clinical trial evaluates the effectiveness of active episodic future thinking (EFT) stimuli for reducing cigarette consumption in cigarette smokers. EFT is an innovative framing method shown to significantly activate brain regions involved in future thinking, planning, and other executive funct...
What is the current status of trial NCT05825001?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 104 participants. The study started on 2024-09-15. Estimated completion is 2026-10-01.
What conditions does trial NCT05825001 study?
This clinical trial studies the following conditions: Cigarette Smoking-Related Carcinoma.
What interventions are being tested in trial NCT05825001?
The interventions under investigation include: Smoking Cessation Intervention (BEHAVIORAL), Medical Device Usage and Evaluation (OTHER), Smoking Cessation Intervention (control) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05825001?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05825001 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking-Related Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05825001's enrollment target sits among peer trials
104 16th of 21 higher than 6 of 21 other Cigarette Smoking-Related Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cigarette Smoking-Related Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial
RECRUITING · NA
-
CONNECTing to LungCare
RECRUITING · NA
-
Smoking Cessation Intervention Development for Homeless Youth
RECRUITING · NA
-
Studying Flavors and Cooling Agents in Oral Nicotine Pouches to Understand User Preferences
RECRUITING · NA
-
Oral Nicotine Pouches Versus Nicotine Replacement Therapy to Reduce Cigarette Use for Smokers in Rural Appalachia
RECRUITING · NA
-
A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI